News
2d
Regtechtimes on MSN🇨🇭 Trump’s tariff blitz hits the Alps — Novartis and Roche brace for tariff pain as Switzerland–U.S. ties collapseSwitzerland, long admired for its calm diplomacy and strict neutrality, has just been hit by a harsh economic surprise. The ...
Novartis AG is weighing a takeover of rare disease-focused biotech firm Avidity Biosciences Inc. in a bid to boost its drug ...
Novartis AG (NYSE:NVS) is one of the top cheap pharmaceutical stocks to buy now. In a report released on August 1, Florent ...
39%? For Switzerland, this is a huge shock, and worse than the worst-case scenario – these are the highest tariffs in Europe.
US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug ...
Its small size and neutrality proved to be no shield. Read more at straitstimes.com. Read more at straitstimes.com.
Switzerland's Novartis on Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and higher-than-forecast prices for a multiple sclerosis (MS) drug.
Research outputs by subject area Subject Count Share Biological sciences 37 10.42 Chemistry 7 3.16 Health sciences 10 4.30 Physical sciences 5 2.27 ...
Switzerland faces highest US tariff at 39% on exports, impacting luxury watches and coffee capsules, risking economic output.
Swiss drugmaker Novartis plans to cut up to 500 jobs in its pharmaceutical division and create new positions across several divisions as it frees up resources to help support the launch of new drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results